Guido Reifenberger
9PUBLICATIONS
123CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Aug 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumors.Pieter Wesseling, David Capper, Guido Reifenberger
|Jan 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.Emilie Le Rhun, Andrea Bink, Joerg Felsberg
|Jun 24, 2024
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?Martin J van den Bent, Pim J French, Daniel Brat
|Dec 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.Tathiane M Malta, Thais S Sabedot, Natalia S Morosini
|Oct 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.Sied Kebir, Vivien Ullrich, Pia Berger
|Apr 01, 2022
Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas.Marietta Wolter, Jörg Felsberg, Bastian Malzkorn
Pageof 2
Frequent Collaborators
5 joint publications
Michael Weller
3 joint publications
Martin van den Bent
2 joint publications
Pieter Wesseling
2 joint publications
David Capper
2 joint publications
Andreas von Deimling
2 joint publications
Pim J French
2 joint publications
Dominique Figarella-Branger
2 joint publications
Felix Sahm
2 joint publications
Houtan Noushmehr
2 joint publications
Kenneth Aldape
